Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy
Latest Publications

TOTAL DOCUMENTS

24

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Springer International Publishing

9783319141503, 9783319141510

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Disruption of DNA Repair by Cell Cycle and Transcriptional CDK Inhibition

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_17 ◽

2015 ◽

pp. 413-430

Author(s):

Liam Cornell ◽

Neil Johnson ◽

Geoffrey I. Shapiro

Keyword(s):

Download Full-text

Targeting Tumour Hypoxia with PARP Inhibitors: Contextual Synthetic Lethality

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_14 ◽

2015 ◽

pp. 345-361

Author(s):

Katarzyna B. Leszczynska ◽

Nadya Temper ◽

Robert G. Bristow ◽

Ester M. Hammond

Keyword(s):

Synthetic Lethality ◽

Parp Inhibitors ◽

Download Full-text

Preclinical Chemosensitization by PARP Inhibitors

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_9 ◽

2015 ◽

pp. 225-260 ◽

Author(s):

David R. Shalinsky ◽

Cherrie K. Donawho ◽

Gerrit Los ◽

Joann P. Palma

Keyword(s):

Parp Inhibitors

Download Full-text

Biomarkers for PARP Inhibitors

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_24 ◽

2015 ◽

pp. 553-579

Author(s):

Charles Dearman ◽

Ricky A. Sharma ◽

Nicola J. Curtin

Keyword(s):

Parp Inhibitors

Download Full-text

PARP Inhibitor Resistance—What Is Beyond BRCA1 or BRCA2 Restoration?

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_19 ◽

2015 ◽

pp. 453-471

Author(s):

Guotai Xu ◽

Jos Jonkers ◽

Sven Rottenberg

Keyword(s):

Parp Inhibitor ◽

Inhibitor Resistance

Download Full-text

Synthetic Sickness with Molecularly Targeted Agents Against the EGFR Pathway

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_16 ◽

2015 ◽

pp. 381-412

Author(s):

Jennifer A. Stanley ◽

Eddy S. Yang

Keyword(s):

Targeted Agents ◽

Molecularly Targeted Agents

Download Full-text

The Vasoactivity of PARP Inhibitors

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_12 ◽

2015 ◽

pp. 299-311

Author(s):

Cian M. McCrudden ◽

Kaye J. Williams

Keyword(s):

Parp Inhibitors

Download Full-text

Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_18 ◽

2015 ◽

pp. 431-452 ◽

Author(s):

Kiranjit K. Dhillon ◽

Toshiyasu Taniguchi

Keyword(s):

Parp Inhibitors

Download Full-text

Discovery of the PARP Superfamily and Focus on the Lesser Exhibited But Not Lesser Talented Members

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_2 ◽

2015 ◽

pp. 15-46 ◽

Author(s):

Eléa Héberlé ◽

Jean-Christophe Amé ◽

Giuditta Illuzzi ◽

Françoise Dantzer ◽

Valérie Schreiber

Download Full-text

PARP and Carcinogenesis

Cancer Drug Discovery and Development - PARP Inhibitors for Cancer Therapy ◽

10.1007/978-3-319-14151-0_5 ◽

2015 ◽

pp. 99-124

Author(s):

Junhui Wang ◽

Akira Sato ◽

Hiroaki Fujimori ◽

Yoshio Miki ◽

Mitsuko Masutani

Download Full-text